Another Xerox healthcare move: reducing readmissions

About two months ago [TTA 13 Nov 14], we noted Xerox’s interesting investment in telehealth/virtual consult kiosk HealthSpot Station. We thought at that time that Xerox was not active in healthcare services and thus found the HealthSpot Station investment unusual. Right on the diagnostics, wrong on the data crunching. Notably, their Midas+ subsidiary concentrates on healthcare quality management, analytics and benchmarking solutions. Midas+ has entered into the readmissions fray by combining its proprietary database, compiled over 1,900 Xerox hospital clients, with five years of Medicare and claims data to help hospitals better predict 30-day same-cause readmissions. The Midas+ Readmission Penalty Forecaster uses the data to project in “near real-time” both patient patterns and reimbursement rates. Commenting to MedCityNews, Justin Lanning, SVP and managing director of Xerox Healthcare Provider Solutions, said the Forecaster has a 1.5 percent margin of error within the predictive model, with quarterly updates provided to participating hospitals. Midas+ also offers, beyond the model, onsite consulting. HealthSpot Station theoretically could throw off a lot of data on outpatient disease and treatment. Midas+ Forecaster white paper, eWeek.

We also note that MedCityNews, one of the livelier publications that covers a wide swath of the US healthcare scene,  is being acquired by Breaking Media, a New York City-based digital publisher. CEO Chris Seper will remain with the publication. Article.

‘eVisits’ save $5 billion globally this year–but are they more effective care?

Deloitte and Towers Watson obviously disagree on the savings from eVisits (Deloitte) and telemedicine (Towers Watson). Deloitte’s study of eVisits projects a global savings of $5 billion in 2014. Towers Watson is estimating $6 billion in 2015 from US employers alone if there is full employee utilization of telemedicine. Deloitte is also more transparent in its estimating, for example on the $50-60 billion total addressable market for eVisits in ‘developed countries’. This Editor doesn’t see a major difference in definitions between the two; Deloitte defines eVisits as video consults plus the forms, questionnaires and photos that have become part of telehealth, but not the vital signs monitoring part.. Perhaps our readers, looking at both more closely, can discern, or confirm that Towers Watson has too rosy a picture? Deloitte‘s ’21st Century Housecall’ study (short paper) is also worth a read for presenting facts/figures on the global addressable market and for a surprising conclusion–that the ‘greater good (in developing countries) may come from saving tens of millions of lives’. Hat tip to reader Mike Clark. Clinical Innovation + Technology summary.

‘Virtual care is much more effective than brick-and-mortar care.” (Editor’s emphasis) A bold statement that Microsoft and the writer from Intel fail to back up with facts. The focus of this ‘In Health’ article is preventing readmissions. There are the usual Panglossian pointers  (more…)